Notable Labs Raises $14.8 Million

According to a recent SEC filing, software startup Notable Labs has raised $14.8 million in financing from an undisclosed investor.

Notable Labs is a personalized testing service for cancer patients. It prioritizes combinations of FDA-approved treatments that can be immediately prescribed by a doctor without clinical trials. Doctors first send samples from patient tumors to Notable Labs. Then, based on the tumor sample, Notable Labs chooses a panel of FDA-approved drugs that have published anticancer effects. The company then tests thousands of combinations of these drugs against the specific tumor and provides a report of the results to patients’ doctors within several days. Upon receipt of the report, the patient’s doctor uses the report to make treatment recommendations customized to that particular tumor.